VEGFA and neoplasm: In this study, immunohistochemically VEGF, HIF-1α, HIF-2α, p53, CD34 (for MVD evaluation), and Ki-67 antibodies were applied to the tumor areas, and the relationships of these antibodies with prognostic factors (FNG, stage, and SD) and survival rates were evaluated.